237 related articles for article (PubMed ID: 2875183)
1. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
[TBL] [Abstract][Full Text] [Related]
2. 6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralin.
Horn AS; Kaptein B; Mulder TB; de Vries JB; Wynberg H
J Med Chem; 1984 Oct; 27(10):1340-3. PubMed ID: 6090664
[TBL] [Abstract][Full Text] [Related]
3. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
4. Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.
Beart PM; Cook CJ; Cincotta M; de Vries DJ; Tepper P; Dijkstra D; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):487-93. PubMed ID: 2963964
[TBL] [Abstract][Full Text] [Related]
5. N,N-disubstituted 2-aminotetralins are potent D-2 dopamine receptor agonists.
Beaulieu M; Itoh Y; Tepper P; Horn AS; Kebabian JW
Eur J Pharmacol; 1984 Oct; 105(1-2):15-21. PubMed ID: 6237927
[TBL] [Abstract][Full Text] [Related]
6. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
Mulder AH; Braakhuis B; De Regt V; Dijkstra D; Horn AS
Eur J Pharmacol; 1980 Jun; 64(4):349-55. PubMed ID: 7389827
[TBL] [Abstract][Full Text] [Related]
7. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.
Hjorth S; Carlsson A
J Neural Transm; 1988; 72(2):83-97. PubMed ID: 2968439
[TBL] [Abstract][Full Text] [Related]
8. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
Makman MH; Dvorkin B; Klein PN
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
Seiler MP; Markstein R
Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
[TBL] [Abstract][Full Text] [Related]
10. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
[TBL] [Abstract][Full Text] [Related]
11. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
12. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
13. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
Seeman P; Woodruff GN; Poat JA
Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
[TBL] [Abstract][Full Text] [Related]
14. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
Murray AM; Waddington JL
Pharmacol Biochem Behav; 1990 Jan; 35(1):105-10. PubMed ID: 1969161
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
Andersen PH; Jansen JA
Eur J Pharmacol; 1990 Jun; 188(6):335-47. PubMed ID: 1973652
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, conformation, and dopaminergic activity of 5,6-ethano-bridged derivatives of selective dopaminergic 3-benzazepines.
Weinstock J; Oh HJ; DeBrosse CW; Eggleston DS; Wise M; Flaim KE; Gessner GW; Sawyer JL; Kaiser C
J Med Chem; 1987 Aug; 30(8):1303-8. PubMed ID: 2886663
[TBL] [Abstract][Full Text] [Related]
17. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
Seiler MP; Markstein R
Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
[No Abstract] [Full Text] [Related]
18. Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.
List SJ; Wreggett KA; Seeman P
J Neurosci; 1982 Jul; 2(7):895-906. PubMed ID: 6124583
[TBL] [Abstract][Full Text] [Related]
19. 5-Oxygenated N-alkyl- and N,N-Dialkyl-2-amino-1-methyltetralins. Effects of structure and stereochemistry on dopamine-D2-receptor affinity.
Grol CJ; Nordvall G; Johansson AM; Hacksell U
J Pharm Pharmacol; 1991 Jul; 43(7):481-5. PubMed ID: 1682460
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives.
Kaiser C; Dandridge PA; Garvey E; Flaim KE; Zeid RL; Hieble JP
J Med Chem; 1985 Dec; 28(12):1803-10. PubMed ID: 4068005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
